Skip to main content

Study M765

Study name

Liao XX 2021

Title

Interaction of serum copper and neurometabolites on executive dysfunction in unmedicated patients with major depressive disorder

Overall design

The aim of this study was to assess whether the interaction between serum copper levels and neurometabolic alterations is involved in the deficit of executive function in patients with unmedicated major depressive disorder (MDD). In this study, 41 patients (MDD group) and 41 healthy controls (control group) underwent proton magnetic resonance spectroscopy (1H-MRS) to obtain ratios of N-acetyl aspartate to creatine (NAA/Cr) and choline-containing compounds to creatine (Cho/Cr) in the lenticular nucleus of basal ganglia.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive disorder; Depression; Depression;

Criteria for depression

DSM-IV diagnosed MDD, HAMD-24 > 20

Sample size

82

Tissue

Central; Brain; Lenticular nucleus;

Platform

MRS; MRS: 3.0 T GE Discovery MR system (General Electric, Milwaukee, WI, USA);

PMID

33746789

DOI

10.3389/fpsyt.2021.564375

Citation

Liao X, Lai S, Zhong S, et al. Interaction of serum copper and neurometabolites on executive dysfunction in unmedicated patients with major depressive disorder. Front Psychiatry. 2021 Mar 3;12:564375.

Metabolite

N-Acetyl aspartate/(Creatine and Phosphocreatine) ratio;